|

The Quebec Court of Appeal upheld the judgment of the Superior Court in the case of Option Consommateurs v. Novopharm et al. by unanimously dismissing the appeal by a consumer advocacy group.  The group had sought court authorization to proceed with a $3.9 billion class action against manufacturers of generic medications in relation to allegations of improper pricing of medications subsidized under the provincial drug insurance system.  Davies represented Pharmascience Inc., a major drug manufacturer.

|

2008